J-GLOBAL ID：200901057864607543
Update date: Mar. 08, 2024
Mitsui Tetsuo
Mitsui Tetsuo
Research field (2)：
Hematology and oncology
, Fetal medicine/Pediatrics
Research theme for competitive and other funds (7)：
2021 - 2025 Analyis of molecular characteristics of refractory/relapsed lymphoblastic lymphoma of children and young adult.
2016 - 2020 Searching leukemia predisposition gene in bone marrow failure syndrome with functional analysis.
2012 - 2016 Clinical and biological significance of granulocyte colony stimulating factor receptor gene abnormalities those found in severe congenital neutropenia.
2008 - 2011 Clinical and biological significance of granulocyte colony stimulating factor receptor gene abnormalities those found in severe congenital neutropenia
2005 - 2007 Clinical and biological significance of granulocyte colony stimulating factor receptor gene abnormalities those found in severe congenital neutropenia
2002 - 2003 Clinical and Biological Significance of Granulocyte-Colony-Stimulating-Factor Receptor Truncation Mutations in Severe Congenital Neutropenia.
1999 - 2000 Molecular Pathology of Hereditary Neuropathy
Show all
Papers (92)：
Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Takeshi Mori, Akiko M Saito, et al. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial. European journal of haematology. 2023
